Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events
November 11, 2023 Comments Off
The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was just approved in the U.S.
Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events
The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was just approved in the U.S.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender